What We're Reading: Page 333
Industry reads hand-picked by our editors
Feb 29, 2016
-
Reuters
Closely watched AstraZeneca cancer drug fails in mesothelioma
-
Bloomberg
His Job Is to Sell a $1,000 Pill for $10 Without Losing Money
-
Stat
Doctors promoting treatments on social media routinely fail to disclose ties to drug makers
-
FierceBiotech
With ataluren under a cloud, PTC plunges (again) after a market setback in Germany
Feb 26, 2016
Feb 25, 2016
Feb 24, 2016
-
C&EN
The Long, Rocky Road From Idea To Successful Biotech
-
Wall Street Journal
Sanofi’s Dengue Vaccine Made Widely Available for First Time
-
Reuters
Texas hospitals say they have developed rapid test for Zika
-
FiercePharma
Top employers aim at Big Pharma with group project to bring down drug costs
-
Boston Globe
Sanofi said to cut more than 30 local research jobs
Feb 23, 2016
-
Stat
The biosimilar ploy that could save billions in health care costs
-
Reuters
FDA says PTC's marketing application insufficient, shares slip
-
Reuters
Bill Gates says Zika response better than for Ebola
-
NY Times
Vaginal Ring With Drug Lowers H.I.V. Rates in African Women
-
The Street
Trevena Pain Drug Anointed 'Breakthrough Therapy' by FDA
Feb 22, 2016
-
Reuters
China research highlights country's excess use of antibiotics
-
Medical Marketing & Media
'Deadpool' Imparts a Lesson to Pharma Marketers
-
Biz Journals
Mylan gets FDA blessing to file generic of powder Advair formulation
Feb 19, 2016
-
Washington Post
Wounded soldier set to receive the first penis transplant in the U.S.
-
Wall Street Journal
Obama Administration Pushes Steps to Aid Puerto Rico With Zika Virus
-
Pharma Times
Novartis' precision leukaemia drug gets breakthrough status
Previous
